Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.6K
Overview
47.6K
Conjugated Proteins02:50

Conjugated Proteins

21.9K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
21.9K
Cancer Vaccines01:30

Cancer Vaccines

586
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
586

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric-onset autoimmune cytopenia: How can we reduce the long-term mortality?

British journal of haematology·2026
Same author

Ribosomal RNA processing impairments in a B cell immunodeficient patient with WDR75 variants.

Journal of human immunity·2026
Same author

Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the interferon response and promotes glycolysis in Aicardi-Goutières syndrome.

Nature communications·2026
Same author

Author Correction: Inactivation of cytidine triphosphate synthase 1 prevents fatal auto-immunity in mice.

Nature communications·2025
Same author

Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patients.

Journal of human immunity·2025
Same author

Lymphedema in patients with X-linked severe combined immunodeficiency.

The journal of allergy and clinical immunology. Global·2025

Related Experiment Video

Updated: Oct 30, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

SARS-CoV-2 vaccines, where do we stand?

Alain Fischer1,2,3

  • 1Collège de France, Paris, France.

Comptes Rendus Biologies
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

COVID-19 vaccination is a key infection control strategy. Rigorous evaluation, mass production, equitable distribution, and clear communication are crucial for vaccine success.

Keywords:
Adenoviral vectorsCovid-19Elinical trialMessengerSARS-CoV2SpikeVaccine ARN

More Related Videos

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.0K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 30, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.0K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • The COVID-19 pandemic necessitates rapid development of effective vaccines.
  • Currently, no definitive treatment exists for COVID-19, making vaccination a primary strategy.
  • Several novel vaccine technologies, including RNA and viral vectors, are under evaluation.

Purpose of the Study:

  • To summarize the current status of SARS-CoV-2 vaccine development.
  • To highlight the importance of rigorous evaluation criteria for vaccine acceptance.
  • To address challenges related to vaccine production, distribution, and public trust.

Main Methods:

  • Review of ongoing SARS-CoV-2 vaccine development projects.
  • Analysis of emerging vaccine technologies (RNA, viral vectors).
  • Consideration of criteria for vaccine efficacy and safety assessment.

Main Results:

  • Multiple vaccine candidates are in human trials, with initial data forthcoming.
  • New vaccine technologies offer diverse approaches to combatting SARS-CoV-2.
  • Rigorous evaluation is essential despite accelerated development timelines.

Conclusions:

  • Successful COVID-19 vaccination requires not only effective vaccines but also robust production and equitable distribution.
  • Building public and professional confidence through quality information and communication is vital for widespread vaccine acceptance.